If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEfg-hold.gdr S Regulatory News (EFGD)

Share Price Information for Efg-hold.gdr S (EFGD)

Share Price is delayed by 15 minutes
Get Live Data
1.00    0.00 (0.00%)
Bid:
1.05
Ask:
1.08
Spread: 0.03 (2.857%)
Market Cap: $717.95m
EFGD Live PriceLast checked at - London Stock Exchange

Intraday Efg-hold.gdr S Share Chart

  • This share is an international stock.

Third Quarter 2016 Results

15 Nov 2016 07:28

RNS Number : 1851P
EFG-Hermes Holdings SAE
15 November 2016
 

EFG HERMES REPORTS THIRD QUARTER 2016GROUP EARNINGS FROM CONTINUED OPERATIONS OF EGP41 MILLION; ON OPERATING REVENUE OF EGP294 MILLION

Cairo, November 15th, 2016 - EFG Hermes reported today net profit after tax and minority interest from continued operations of EGP41 million in 3Q16, up 3% Y-o-Y. Operating revenue rose 28% Y-o-Y to EGP294 million in 3Q16. Net profit after tax and minority interest from continued and discontinued operations reached EGP151 million, up 25% Y-o-Y in 3Q16. The Group total assets stood at EGP14.0 billion at the end of 3Q16.http://www.rns-pdf.londonstockexchange.com/rns/1851P_-2016-11-15.pdf

http://www.rns-pdf.londonstockexchange.com/rns/1851P_1-2016-11-15.pdf

Key Highlights

3Q2016

 

· EFG Hermes reported buoyant results in 3Q16 despite a seasonally weak quarter; with the burgeoning non-bank finance platform supporting the overall performance. The Firm reported a net profit after tax and minority interest from continued operations of EGP41 million, up 3% Y-o-Y in 3Q16;

· On the operational level, the Firm recorded a net operating profit of EGP76 million, up 7% Y-o-Y; as higher revenues overshadowed higher expenses;

· Total operating revenues increased 28% Y-o-Y to EGP294 million in 3Q16; predominantly on strong revenue generated from the growing non-bank finance platform, higher contribution from one of our core segments, namely Brokerage, and capital gain realized from seed capital redemption;

· Total operating expenses rose 37% Y-o-Y to EGP219 million in 3Q16; mainly on additional costs associated with the new businesses, Leasing and Tanmeyah. However, employee expenses/ operating revenue came at 47% in 3Q16; an accomplishment given the rising inflationary pressures, and the EGP devaluation in 1Q16 which impacts our overseas salaries;

· During the period, EFG Hermes reported a net profit after tax and minority interest from continued and discontinued operations of EGP151 million, up 25% Y-o-Y in 3Q16; reflecting the adjustment of impairment charges booked in 1Q16 and associated with the sale of Credit Libanais. This comes in accordance with the Egyptian Accounting Standards, which necessitates an adjustment in the occurrence of a subsequent material event - the EGP devaluation;

· We continue to divest our remaining stake in Credit Libanais post the sale of our majority stake in the Bank and its subsequent deconsolidation in 2Q16. In 3Q16, we offloaded an additional 3.3% of the Bank's shares, thus leaving the Firm with 16.1% stake at the end of the period.

 

 

For full report and financial statements, please click on the links on top of the page.

 

 

For further information:

Investor Relations Contacts

Email: investor-relations@efg-hermes.com

Head of Investor Relations

Hanzada Nessim

Email: hnessim@efg-hermes.com

Tel: +20 (0)2 35356502

Fax: +20(0)2 3535 7017

www.efg-hermes.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTDELBFQFFLFBX
Date   Source Headline
22nd May 20139:04 amRNS1st Quarter Results
14th May 20139:45 amRNSResult of Board Meeting
2nd May 20138:39 amRNSExpiration of QInvest JV Agreement
2nd May 20138:39 amRNSStrategy following Expiration of QInvest agreement
16th Apr 201312:08 pmRNSStatement re QInvest Deal
3rd Apr 20139:08 amRNSFY2012 Results
2nd Apr 20133:45 pmRNSSecond Price Monitoring Extn
2nd Apr 20133:40 pmRNSPrice Monitoring Extension
21st Mar 20137:28 amRNSCourt declines freeze of CEOs assets
18th Mar 20138:46 amRNSFreezing of CEOs Assets
19th Nov 20128:32 amRNS3rd Quarter Results
9th Nov 20123:45 pmRNSSecond Price Monitoring Extn
9th Nov 20123:40 pmRNSPrice Monitoring Extension
15th Oct 20128:35 amRNSStatement re EFSA certifies EGM
17th Sep 20127:00 amRNSEGM Statement
31st Aug 20127:00 amRNSNotice of EGM
30th Aug 20123:25 pmRNSStatement re Board of Directors Resolutions
15th Aug 201210:03 amRNSHalf Yearly Report
26th Jul 20129:45 amRNSEGM Statement
12th Jun 201211:45 amRNSClarification
8th Jun 20123:45 pmRNSSecond Price Monitoring Extn
8th Jun 20123:40 pmRNSPrice Monitoring Extension
6th Jun 20127:00 amRNSStatement re Legal Action
6th Jun 20127:00 amRNS1st Quarter Results
6th Jun 20127:00 amRNSResults of AGM and EGM
31st May 201211:17 amRNSStatement
31st May 20128:58 amRNSStatement from EFG Hermes
31st May 20128:53 amRNSStatement re. Press Comment
30th May 201211:09 amRNSStatement re BoD Resolutions
16th May 20124:09 pmRNSAGM & EGM Invitation - Replacement
16th May 20129:42 amRNSAGM & EGM Invitation
10th May 20123:45 pmRNSSecond Price Monitoring Extn
10th May 20123:40 pmRNSPrice Monitoring Extension
8th May 20127:00 amRNSRe Agreement
26th Apr 20129:23 amRNSStatement re. Press Comment
25th Apr 20123:45 pmRNSSecond Price Monitoring Extn
25th Apr 20123:40 pmRNSPrice Monitoring Extension
10th Apr 20127:00 amRNSFY2011 Results
28th Mar 20129:36 amRNSStatement re Damas International Limited
26th Mar 20128:49 amRNSStatement re Strategic Alliance with QInvest
19th Mar 201211:07 amRNSStatement re. Press Comment
14th Feb 20129:33 amRNSStatement re CEO Travel Ban
8th Feb 20128:33 amRNSStatement re CEO Travel Ban
6th Feb 20127:42 amRNSStatement re - CEO Travel Ban
17th Jan 20123:45 pmRNSSecond Price Monitoring Extn
17th Jan 20123:40 pmRNSPrice Monitoring Extension
16th Nov 20119:28 amRNS3rd Quarter Results
10th Oct 20113:45 pmRNSSecond Price Monitoring Extn
10th Oct 20113:40 pmRNSPrice Monitoring Extension
4th Oct 20119:53 amRNSStatement re. Press Comment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.